Skolarus, Ted A.
Forman, Jane
Sparks, Jordan B.
Metreger, Tabitha
Hawley, Sarah T.
Caram, Megan V.
Dossett, Lesly
Paniagua-Cruz, Alan
Makarov, Danil V.
Leppert, John T.
Shelton, Jeremy B.
Stensland, Kristian D.
Hollenbeck, Brent K.
Shahinian, Vahakn
Sales, Anne E.
Wittmann, Daniela A.
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (R01 CA242559, R37 CA222885)
Article History
Received: 17 December 2020
Accepted: 30 September 2021
First Online: 28 October 2021
Change Date: 20 March 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s43058-023-00411-9
Declarations
:
: This study has been approved by the VA Ann Arbor Healthcare System IRB (IRB-2017-1047) and the University of Michigan IRB (HUM00133932). As this study is conducted solely by phone and by mail and is considered minimal risk, a waiver of documentation of signed informed consent and HIPAA Authorization was approved. Verbal informed consent was obtained for all patients participating in the research. Further information and documentation on IRB approval are available upon request.
: All authors consent for the manuscript to be published.
: The authors declare that they have no competing interests. Dr. Skolarus is a prostate cancer survivorship author for UpToDate™. The authors declare that Anne Sales is co-Editor-in-Chief of the journal.